To investigate the immunomodulatory potential of IL-21 aimed at improving influenza vaccine responses in aged SIV+ RMs, we compared serum influenza HAI titers among aged SIV+ IL-21–untreated (n = 4) and aged SIV+ IL-21–treated (n = 8) RMs (Figure 1D). This evidence concerns the gene IL21 and influenza.